![](https://investorshub.advfn.com/uicon/123346.png?cb=1487558083)
Thursday, February 05, 2015 5:06:44 PM
Court of Appeals Order – Retractable Technologies, Inc., et al., v. Becton, Dickinson and Co (2/05/15)
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE MKT: RVP) (“RTI”) announced today that on February 3, 2015 the United States Court of Appeals for the Fifth Circuit issued an order which denied Becton, Dickinson and Co.’s (“BD”) motion for stay of injunction pending appeal.
In previous press releases, RTI has reiterated the requirements of the injunction at issue, which, among other things, require BD to notify its customers and others that it wrongfully distributed false and misleading advertisements. Except to the extent stayed by the District Court’s January 14 order, the notices required by the injunction must be sent by BD no later than February 14, 2015. BD had requested a stay of the injunction pending appeal. The Fifth Circuit opinion did not expand on its reasoning for denying BD’s motion.
Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. Retractable's products are distributed by various specialty and general line distributors.
For more information on Retractable, visit our website at www.vanishpoint.com.
http://www.businesswire.com/news/home/20150205005248/en/Court-Appeals-Order-%E2%80%93-Retractable-Technologies-al.#.VNOEg4ktGUk
*This lawsuit can't be good for BDX...expect fallout by mid-month if not sooner.
Marker;
Becton, Dickinson An (BDX)
$145.29 up 5.37 (3.84%)
Volume: 1,785,511
If liabilities are greater than assets, the business is insolvent. Knowing the structure of those liabilities is where to make your money. -- EI2010
Recent BDX News
- BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases • PR Newswire (US) • 07/25/2024 10:45:00 AM
- BD Board Declares Dividend • PR Newswire (US) • 07/23/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 10:01:14 AM
- Costco Hikes Membership Fees; ON Semiconductor Stock Drops 3%; WD-40 Soars 13% on Strong Q3 Earnings • IH Market News • 07/11/2024 10:17:26 AM
- BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials • PR Newswire (US) • 07/10/2024 04:12:00 PM
- BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023 • PR Newswire (US) • 07/10/2024 10:50:00 AM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 07/08/2024 07:54:01 PM
- BD to Announce Financial Results for its Third Quarter of Fiscal 2024 • PR Newswire (US) • 07/03/2024 12:30:00 PM
- New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases • PR Newswire (US) • 06/26/2024 10:45:00 AM
- BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts • PR Newswire (US) • 06/20/2024 12:30:00 PM
- Form 8-A12B - Registration of securities [Section 12(b)] • Edgar (US Regulatory) • 06/12/2024 12:45:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 05:45:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2024 08:59:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 09:04:43 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 06/06/2024 09:06:33 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 06/06/2024 09:05:03 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 06/06/2024 09:03:40 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 06/04/2024 09:27:27 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 06/04/2024 09:26:24 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 06/04/2024 09:25:41 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 06/04/2024 12:26:52 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 06/04/2024 10:04:58 AM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 06/04/2024 10:01:54 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 10:33:34 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM